Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jon B Toledo

Showing results (1-10 of 105) with videos related to

Pageof 11
Sort By:
Alzheimer'S Research & Therapy|March 9, 2013
Plasma amyloid beta measurements - a desired but elusive Alzheimer's disease biomarkerJon B Toledo, Leslie M Shaw, John Q Trojanowski
Alzheimer'S Research & Therapy|December 20, 2024
Cognitive decline profiles associated with lewy pathology in the context of Alzheimer's disease neuropathologic changeJon B Toledo, David P Salmon, Melissa J Armstrong, et al.
Parkinsonism & Related Disorders|June 19, 2022
Subacute tremor and ataxia: Diligence in pursuit of a diagnosisJessica Frey, Jon B Toledo, Adolfo Ramirez-Zamora, et al.
Acta Neuropathologica|July 2, 2013
Longitudinal change in CSF Tau and Aβ biomarkers for up to 48 months in ADNIJon B Toledo, Sharon X Xie, John Q Trojanowski, et al.
Scientific Reports|October 23, 2025
The cognitive connectome in dementia with lewy bodies undergoes early alterations already at the mild cognitive impairment stageRoraima Yanez-Perez, Annegret Habich, Jon B Toledo, et al.
Acta Neuropathologica|July 2, 2013
CSF α-synuclein improves diagnostic and prognostic performance of CSF tau and Aβ in Alzheimer's diseaseJon B Toledo, Ane Korff, Leslie M Shaw, et al.
Alzheimer'S Research & Therapy|December 6, 2014
Low levels of cerebrospinal fluid complement 3 and factor H predict faster cognitive decline in mild cognitive impairmentJon B Toledo, Ané Korff, Leslie M Shaw, et al.
Clinical Chemistry|March 23, 2013
Clinical utility and analytical challenges in measurement of cerebrospinal fluid amyloid-β(1-42) and τ proteins as Alzheimer disease biomarkersJu-Hee Kang, Magdalena Korecka, Jon B Toledo, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 15, 2017
Patterns of coordinated cortical remodeling during adolescence and their associations with functional specialization and evolutionary expansionAristeidis Sotiras, Jon B Toledo, Raquel E Gur, et al.
IEEE Transactions on Emerging Topics in Computational Intelligence|March 27, 2023
ADCoC: Adaptive Distribution Modeling Based Collaborative Clustering for Disentangling Disease Heterogeneity from Neuroimaging DataHangfan Liu, Michel J Grothe, Tanweer Rashid, et al.
Pageof 11

Showing results (1-10 of 105) with videos related to

Sort By:
Pageof 11
Alzheimer'S Research & Therapy|March 9, 2013
Plasma amyloid beta measurements - a desired but elusive Alzheimer's disease biomarkerJon B Toledo, Leslie M Shaw, John Q Trojanowski
Alzheimer'S Research & Therapy|December 20, 2024
Cognitive decline profiles associated with lewy pathology in the context of Alzheimer's disease neuropathologic changeJon B Toledo, David P Salmon, Melissa J Armstrong, et al.
Parkinsonism & Related Disorders|June 19, 2022
Subacute tremor and ataxia: Diligence in pursuit of a diagnosisJessica Frey, Jon B Toledo, Adolfo Ramirez-Zamora, et al.
Acta Neuropathologica|July 2, 2013
Longitudinal change in CSF Tau and Aβ biomarkers for up to 48 months in ADNIJon B Toledo, Sharon X Xie, John Q Trojanowski, et al.
Scientific Reports|October 23, 2025
The cognitive connectome in dementia with lewy bodies undergoes early alterations already at the mild cognitive impairment stageRoraima Yanez-Perez, Annegret Habich, Jon B Toledo, et al.
Acta Neuropathologica|July 2, 2013
CSF α-synuclein improves diagnostic and prognostic performance of CSF tau and Aβ in Alzheimer's diseaseJon B Toledo, Ane Korff, Leslie M Shaw, et al.
Alzheimer'S Research & Therapy|December 6, 2014
Low levels of cerebrospinal fluid complement 3 and factor H predict faster cognitive decline in mild cognitive impairmentJon B Toledo, Ané Korff, Leslie M Shaw, et al.
Clinical Chemistry|March 23, 2013
Clinical utility and analytical challenges in measurement of cerebrospinal fluid amyloid-β(1-42) and τ proteins as Alzheimer disease biomarkersJu-Hee Kang, Magdalena Korecka, Jon B Toledo, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 15, 2017
Patterns of coordinated cortical remodeling during adolescence and their associations with functional specialization and evolutionary expansionAristeidis Sotiras, Jon B Toledo, Raquel E Gur, et al.
IEEE Transactions on Emerging Topics in Computational Intelligence|March 27, 2023
ADCoC: Adaptive Distribution Modeling Based Collaborative Clustering for Disentangling Disease Heterogeneity from Neuroimaging DataHangfan Liu, Michel J Grothe, Tanweer Rashid, et al.
Pageof 11